128 related articles for article (PubMed ID: 29955477)
21. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
Warden BA; Shapiro MD; Fazio S
Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
[No Abstract] [Full Text] [Related]
22. Effect of pharmacists' clinical interventions on nonformulary drug use.
Packer LA; Mahoney CD; Rich DS; Jeffrey LP
Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
[TBL] [Abstract][Full Text] [Related]
23. Cost savings and avoidance from clinical interventions.
Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
[TBL] [Abstract][Full Text] [Related]
24. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
[TBL] [Abstract][Full Text] [Related]
25. Pharmacists as Care Providers for Stroke Patients: A Systematic Review.
Basaraba JE; Picard M; George-Phillips K; Mysak T
Can J Neurol Sci; 2018 Jan; 45(1):49-55. PubMed ID: 28929979
[TBL] [Abstract][Full Text] [Related]
26. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
[TBL] [Abstract][Full Text] [Related]
27. Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.
Kiskaddon AL; Smith MM; Gilliland F; Rech MA
Crit Care Explor; 2023 Oct; 5(10):e0980. PubMed ID: 37811129
[TBL] [Abstract][Full Text] [Related]
28. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
29. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of clinical pharmacist interventions in paediatric hospital patients.
Drovandi A; Robertson K; Tucker M; Robinson N; Perks S; Kairuz T
Eur J Pediatr; 2018 Aug; 177(8):1139-1148. PubMed ID: 29915870
[TBL] [Abstract][Full Text] [Related]
31. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
Surbhi S; Munshi KD; Bell PC; Bailey JE
J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
[TBL] [Abstract][Full Text] [Related]
32. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
33. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
35. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
36. Implementation of clinical pharmacist recommendations and services at a University Hospital in Yemen.
Kubas MA; Halboup AM
Int J Clin Pharm; 2020 Feb; 42(1):51-56. PubMed ID: 31713107
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy.
Lombardi N; Wei L; Ghaleb M; Pasut E; Leschiutta S; Rossi P; Troncon MG
BMC Health Serv Res; 2018 Apr; 18(1):259. PubMed ID: 29631587
[TBL] [Abstract][Full Text] [Related]
38. Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital.
Stuhec M; Tement V
Sci Rep; 2021 Jul; 11(1):13641. PubMed ID: 34211019
[TBL] [Abstract][Full Text] [Related]
39. Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study.
Yang H; Li L; Hu X; Wang W; Yang X; Liu H; Ren L; Zhang X; Liu L
J Clin Pharm Ther; 2019 Aug; 44(4):603-610. PubMed ID: 30883843
[TBL] [Abstract][Full Text] [Related]
40. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
